EP 1861121 A4 20090121 - HIV VACCINE COMPOSITION
Title (en)
HIV VACCINE COMPOSITION
Title (de)
HIV-IMPFSTOFFZUSAMMENSETZUNG
Title (fr)
COMPOSITION DE VACCIN ANTI-VIH
Publication
Application
Priority
- CA 2006000295 W 20060228
- US 65690805 P 20050301
Abstract (en)
[origin: WO2006092046A1] An anti-HIV vaccine composition is disclosed. The vaccine comprises an combination of immunogenic peptide mixtures, which mixtures may be prepared in a single synthesis. The composition collectively represents the in vivo variability seen in immunogenic epitopes from highly variable regions of HIV. Immunization with the vaccine elicits broadly reactive immunity (CTL and T helper cell responses) against the divergent strains of HIV upon which it is based. The vaccine may be formulated to target regionally distinct variability based on an HIV clade predominant in a geographical region.
IPC 8 full level
A61K 39/21 (2006.01); A61K 38/16 (2006.01)
CPC (source: EP US)
A61K 38/162 (2013.01 - EP US); A61P 31/18 (2017.12 - EP)
Citation (search report)
- [T] AZIZI ALI ET AL: "Induction of broad cross-subtype-specific HIV-1 immune responses by a novel multivalent HIV-1 peptide vaccine in cynomolgus macaques", JOURNAL OF IMMUNOLOGY, vol. 180, no. 4, February 2008 (2008-02-01), pages 2174 - 2186, XP002507433, ISSN: 0022-1767
- See references of WO 2006092046A1
Designated contracting state (EPC)
AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
DOCDB simple family (publication)
WO 2006092046 A1 20060908; AT E552847 T1 20120415; CA 2540279 A1 20060614; CA 2540279 C 20091020; EP 1861121 A1 20071205; EP 1861121 A4 20090121; EP 1861121 B1 20120411; US 2009117141 A1 20090507; US 8029797 B2 20111004
DOCDB simple family (application)
CA 2006000295 W 20060228; AT 06705249 T 20060228; CA 2540279 A 20060228; EP 06705249 A 20060228; US 81764006 A 20060228